| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 09.02.
| A Forward Look, the Year Ahead - Featured Research on Acorda Therapeutics Inc and Abbott Laboratories | | 26 | MarketWire |
| HONG KONG -- (Marketwire) -- 02/09/12 -- Today, www.BollingerReport.com introduced featured coverage of Acorda Therapeutics Inc (NASDAQ: ACOR) and Abbott Laboratories (NYSE: ABT). Full research reports...
Mehr lesen zu:
A Forward Look, the Year Ahead - Featured Research on Acorda Therapeutics Inc and Abbott Laboratories | |
| 09.02.
| Acorda Therapeutics to Present at Leerink Swann 2012 Global Healthcare Conference | | 35 | Business Wire |
| Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Ron Cohen,
M.D., President & CEO, will present at the Leerink Swann 2012 Global
Healthcare Conference on...
Mehr lesen zu:
Acorda Therapeutics to Present at Leerink Swann 2012 Global Healthcare Conference | |
| 09.02.
| Acorda Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2011 Financial Results on February 16, 2012 | | 19 | Business Wire |
| Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it will
host a conference call and live webcast to report its fourth quarter and
full year 2011 financial...
Mehr lesen zu:
Acorda Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2011 Financial Results on February 16, 2012 | |
| 08.02.
| Acorda Therapeutics Crosses Below its 10-day MA | | - | SmarTrend |
| 07.02.
| Acorda Therapeutics to Present at 14th Annual BIO CEO & Investor Conference | | 44 | Business Wire |
| Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Ron Cohen,
M.D., President & CEO, will present at 14th Annual BIO CEO & Investor
Conference on Tuesday, February...
Mehr lesen zu:
Acorda Therapeutics to Present at 14th Annual BIO CEO & Investor Conference | |
| 07.02.
| Acorda, Watson partner to introduce generic zanaflex capsules | | - | Pharma Bus Review |
| 06.02.
| Acorda Therapeutics Announces Launch of Authorized Generic Version of ZANAFLEX CAPSULES® | | 50 | Business Wire |
| Acorda Therapeutics, Inc. (Nasdaq: ACOR)
today announced that the Company has partnered with Watson Pharma, Inc.,
a subsidiary of Watson Pharmaceuticals, Inc. (NYSE: WPI)...
Mehr lesen zu:
Acorda Therapeutics Announces Launch of Authorized Generic Version of ZANAFLEX CAPSULES® | |
| 03.02.
| Acorda Therapeutics Presents Preclinical Data Showing Dalfampridine Improves Motor Function in Chronic Stroke | | 51 | Business Wire |
| First ever data to demonstrate improvement in motor function following
stroke with oral drug treatment initiated several weeks after event
...
Mehr lesen zu:
Acorda Therapeutics Presents Preclinical Data Showing Dalfampridine Improves Motor Function in Chronic Stroke | |
| 30.01.
| Acorda Therapeutics Shares Up 14.8% Since SmarTrend's Buy Recommendation | | - | SmarTrend |
| 18.01.
| Acorda Therapeutics Shares Up 15.3% Since SmarTrend's Buy Recommendation | | 1 | SmarTrend |
| 09.01.
| Stock Investors Bid Up Shares of Acorda Therapeutics, Up 5.3% | | - | SmarTrend |
| 09.01.
| Acorda Therapeutics Provides 2012 Corporate Update at 30th Annual J.P. Morgan Healthcare Conference | | 24 | Business Wire |
| AMPYRA 2011 Q4 Net Sales of $57 Million (unaudited) and 2011 Full-Year
Net Sales of $210 Million (unaudited)
AMPYRA 2012 Net Sales Guidance...
Mehr lesen zu:
Acorda Therapeutics Provides 2012 Corporate Update at 30th Annual J.P. Morgan Healthcare Conference | |
| 28.12.
| Acorda Therapeutics to Present at the 30th Annual J.P. Morgan Healthcare Conference | | 36 | Business Wire |
| Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Ron Cohen,
M.D., President & CEO, will present at the 30th Annual
J.P. Morgan Healthcare Conference on Monday...
Mehr lesen zu:
Acorda Therapeutics to Present at the 30th Annual J.P. Morgan Healthcare Conference | |
| 27.12.
| ACORDA - Nur noch eine Hürde voraus | | 4 | GodmodeTrader.de |
| 22.11.
| Acorda Therapeutics to Present at the Piper Jaffray 23rd Annual Healthcare Conference | | 23 | Business Wire |
| Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Ron Cohen,
M.D., President & CEO, will present at the Piper Jaffray 23rd
Annual Healthcare Conference on...
Mehr lesen zu:
Acorda Therapeutics to Present at the Piper Jaffray 23rd Annual Healthcare Conference | |
| 16.11.
| Acorda (ACOR) Presents Encouraging GGF2 Preclinical Data | | - | StreetInsider.com |
| 16.11.
| Acorda Therapeutics Announces Preclinical Data on GGF2 in Heart Failure Presented at American Heart Association Scientific Sessions 2011 | | 20 | Business Wire |
| Acorda Therapeutics, Inc. (Nasdaq: ACOR)
today announced that preclinical data from a study of its
investigational drug Glial Growth Factor 2 (GGF2) showed GGF2
...
Mehr lesen zu:
Acorda Therapeutics Announces Preclinical Data on GGF2 in Heart Failure Presented at American Heart Association Scientific Sessions 2011 | |
| 08.11.
| Acorda Therapeutics to Present at the Lazard Capital Markets 8th Annual Healthcare Conference | | 34 | Business Wire |
| Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Ron Cohen,
M.D., President & CEO, will present at the Lazard Capital Markets 8th
Annual Healthcare Conference...
Mehr lesen zu:
Acorda Therapeutics to Present at the Lazard Capital Markets 8th Annual Healthcare Conference | |
| 07.11.
| ACORDA THERAPEUTICS INC - 10-Q, Quarterly Report | | - | SEC Filings |
| 07.11.
| Professional Outlook, Will EU's Deal Hold the Markets? - Equity Research on Acorda Therapeutics Inc. and BioMarin Pharmaceutical Inc. | | 7 | MarketWire |
| MACAU -- (Marketwire) -- 11/07/11 -- Today, www.EquityMarketsInc.com announced its research report highlighting Acorda Therapeutics Inc. (NASDAQ: ACOR) and BioMarin Pharmaceutical Inc. (NASDAQ: BMRN)....
Mehr lesen zu:
Professional Outlook, Will EU's Deal Hold the Markets? - Equity Research on Acorda Therapeutics Inc. and BioMarin Pharmaceutical Inc. | |
